ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000260572.1	Gefitinib	Cervical squamouscell carcinoma and endocervical adenocarcinoma	0.04748258	Resistant
ENSG00000260572.1	Gefitinib	Breast invasive carcinoma	0.042183373	Sensitive